Predicting Deckers Outdoor Corp’s (DECK) earnings for the current quarter

Deckers Outdoor Corp (DECK)’s stock is trading at $110.07 at the moment marking a fall of -1.82% from the last session close. As of this writing, shares are priced at -50.86% less than their 52-week high of $223.98, and 17.44% over their 52-week low of $93.72.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, DECK’s SMA-200 is $146.09.

Further, it is important to consider DECK stock ratios, particularly its price-to-sales ratio over the past twelve months, which stands at 3.18.Likewise, its price to free cash flow for the last twelve months stands at 17.04. DECK’s price to book ratio for the most recent quarter was 6.58, resulting in an 9.49 price to cash per share for the period.

How does Deckers Outdoor Corp (DECK) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.

Deckers Outdoor Corp (DECK): Earnings History

If we examine Deckers Outdoor Corp’s recent earnings history, in the last quarter ended on 6/30/2025, it posted adjusted earnings per share of $0.93, slashing the consensus of $0.68. In other words, it topped the consensus by $0.25, resulting in a 36.60% surprise. In the 3 months period before the previous quarter which was closed on 6/30/2025, the stock recorded adjusted earnings per share of $0.93 in contrast with the Outlook of $0.68. That was a difference of $0.25 and a surprise of 36.60%.

Deckers Outdoor Corp (NYSE: DECK) Ownership Details

I will give a breakdown of the key shareholders in Deckers Outdoor Corp (DECK). Recent figures show that the company’s insiders hold 0.48% of shares. A total of 1,298 institutional investors hold shares in the company, making 102.25% of its stock and 102.74% of its float.

Mar 31, 2025 , it was reported that the Company’s largest institutional holder is FMR, LLC holding total of 22.77 shares that make 15.33% of the company’s total number of shares and are currently priced at 2.51 billion.

The securities firm Vanguard Group Inc holds 17.75 shares of DECK, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 11.95% , and the holding percentage of shares is valued at 1.96 billion.

An overview of Deckers Outdoor Corp’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Deckers Outdoor Corp (DECK) traded 4,454,398 shares per day, with a moving average of $105.25 and price change of +4.66. With the moving average of $106.75 and a price change of -17.85, about 4,140,907 shares changed hands on average over the past 50 days. Finally, DECK’s 100-day average volume is 3,631,237 shares, alongside a moving average of $110.92 and a price change of -21.87.

Hot this week

Ultragenyx Pharmaceutical Inc’s results are impressive

While Ultragenyx Pharmaceutical Inc has underperformed by -1.88%, investors...

Did Arcturus Therapeutics Holdings Inc (ARCT) perform well in the last session?

While Arcturus Therapeutics Holdings Inc has underperformed by -2.99%,...

Should investors be concerned about Grupo Financiero Galicia ADR (GGAL)?

While Grupo Financiero Galicia ADR has underperformed by -1.35%,...

Is Vera Therapeutics Inc (VERA) worth investing in despite its overvalued state?

While Vera Therapeutics Inc has overperformed by 1.79%, investors...

Are CorMedix Inc (CRMD) shares a good deal now?

While CorMedix Inc has underperformed by -0.86%, investors are...

Topics

Ultragenyx Pharmaceutical Inc’s results are impressive

While Ultragenyx Pharmaceutical Inc has underperformed by -1.88%, investors...

Did Arcturus Therapeutics Holdings Inc (ARCT) perform well in the last session?

While Arcturus Therapeutics Holdings Inc has underperformed by -2.99%,...

Should investors be concerned about Grupo Financiero Galicia ADR (GGAL)?

While Grupo Financiero Galicia ADR has underperformed by -1.35%,...

Is Vera Therapeutics Inc (VERA) worth investing in despite its overvalued state?

While Vera Therapeutics Inc has overperformed by 1.79%, investors...

Are CorMedix Inc (CRMD) shares a good deal now?

While CorMedix Inc has underperformed by -0.86%, investors are...

Talkspace Inc (TALK) requires closer examination

While Talkspace Inc has underperformed by -0.40%, investors are...

ODDITY Tech Ltd (ODD) shows promising results

While ODDITY Tech Ltd has underperformed by -0.29%, investors...

What was Groupon Inc (GRPN)’s performance in the last session?

While Groupon Inc has overperformed by 0.92%, investors are...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.